Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis

被引:26
|
作者
Bensi, C. [1 ]
Marrodan, M. [1 ]
Gonzalez, A. [2 ]
Chertcoff, A. [3 ]
Osa Sanz, E. [4 ]
Chaves, H. [4 ]
Schteinschnaider, A. [5 ]
Correale, J. [1 ,6 ]
Farez, M. F. [6 ,7 ]
机构
[1] Inst Neurol Res Dr Raul Carrea FLENI, Dept Neurol, Buenos Aires, DF, Argentina
[2] HIBA, Dept Neuropediat, Buenos Aires, DF, Argentina
[3] Hosp Britanico Buenos Aires, Dept Neurol, Buenos Aires, DF, Argentina
[4] Inst Neurol Res Dr Raul Carrea FLENI, Dept Diagnost Imaging, Buenos Aires, DF, Argentina
[5] Inst Neurol Res Dr Raul Carrea FLENI, Dept Neuropediat, Buenos Aires, DF, Argentina
[6] Inst Neurol Res Dr Raul Carrea FLENI, Ctr Res Neuroimmunol Dis CIEN, Montaneses 2325, Buenos Aires, DF, Argentina
[7] Inst Neurol Res Dr Raul Carrea FLENI, Ctr Biostat Epidemiol & Publ Hlth CEBES, Buenos Aires, DF, Argentina
关键词
Neuromyelitis optica; Neuromyelitis optica spectrum disorders; Multiple sclerosis; MOG; SPECTRUM; NMO; MS;
D O I
10.1016/j.msard.2018.08.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Test the ability of a brain and spinal cord MRI criteria to differentiate neuromyelitis optica spectrum disorders and MOG-disease from MS. MRI criteria was further tested in patients with CIS and pediatric MS. Background: MOG-disease and neuromyelitis optica spectrum disorders can present clinical and radiological features strikingly similar to those of MS. Previously, diagnostic criteria based on brain MRI have been proposed to distinguish between these demyelinating diseases (Matthews-Jurynczik criteria), but spinal cord imaging and its relevance in CIS have not been evaluated. Simple brain and spinal cord MRI criteria may help separate these three inflammatory CNS diseases both in adults and children, aiding in early diagnostic decision-making, such as need for antibody testing. Design/methods: We included 150 participants (23 with aquaporin-4-positive neuromyelitis optica spectrum disorder, 14 with MOG-disease, 20 with aquaporin-4-negative neuromyelitis optica spectrum disorder, 48 with adult-onset relapsing remitting MS, 24 with pediatric-onset MS and 21 with clinically isolated syndrome). Brain and spinal cord MRI scans were anonymised and scored by 2 separate raters, based on two sets of criteria: one previously described by Matthews and colleagues (including presence of at least one lesion adjacent to the body of lateral ventricle and in the inferior temporal lobe, or presence of subcortical U-fiber lesion or a Dawson's finger-type lesion), and an extended version including spinal cord features (non-longitudinally extensive cervical lesion). Results: Extended MRI brain and spinal cord lesion criteria were able to separate adult-onset relapsing remitting MS with 100% sensitivity and 87% specificity from aquaporin-4-positive neuromyelitis optica spectrum disorder; and with 100% sensitivity and 79% specificity from MOG-disease. Additionally, brain and spinal cord criteria showed 100% sensitivity and specificity in patients presenting optic neuritis. Brain and spinal cord criteria were less sensitive in patients with CIS and in pediatric MS patients. Conclusions: Our data suggest radiological criteria can be useful to separate MS from MOG- and aquaporin-4-positive neuromyelitis optica spectrum disorders, in particular in patients with optic neuritis. Further work is needed to support their use in CIS.
引用
收藏
页码:246 / 250
页数:5
相关论文
共 50 条
  • [1] Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis
    Bensi, C.
    Marrodan, M.
    Gonzalez, A.
    Chertcoff, A.
    Osa Sanz, E.
    Schteinschnaider, A.
    Correale, J.
    Farez, M.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 330 - 331
  • [2] The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis
    Messina, Silvia
    Mariano, Romina
    Geraldes, Ruth
    Kim, Su-Hyun
    Satukijcha, Chanjira
    Vecchio, Domizia
    Chua, Yi Yi
    Taylor, James
    George, Naveen
    Cavey, Ana
    Diaz, Alejandro Rubio
    Reeve, Sandra
    Everett, Rosie
    De Luca, Gabriele
    Leite, Maria Isabel
    Kim, Ho Jin
    Palace, Jacqueline
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 49
  • [3] Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica
    Ciotti, John R.
    Eby, Noah S.
    Wu, Gregory F.
    Naismith, Robert T.
    Chahin, Salim
    Cross, Anne H.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 45
  • [4] Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder
    Cacciaguerra, Laura
    Morris, Pearse
    Tobin, W. Oliver
    Chen, John J.
    Banks, Samantha A.
    Elsbernd, Paul
    Redenbaugh, Vyanka
    Tillema, Jan-Mendelt
    Montini, Federico
    Sechi, Elia
    Lopez-Chiriboga, A. Sebastian
    Zalewski, Nicholas
    Guo, Yong
    Rocca, Maria A.
    Filippi, Massimo
    Pittock, Sean J.
    Lucchinetti, Claudia F.
    Flanagan, Eoin P.
    NEUROLOGY, 2023, 100 (13) : E1418 - E1432
  • [5] Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis
    Mariano, Romina
    Messina, Silvia
    Roca-Fernandez, Adriana
    Leite, Maria, I
    Kong, Yazhuo
    Palace, Jacqueline A.
    BRAIN, 2021, 144 : 198 - 212
  • [6] Brain and spinal cord MRI lesion criteria differentiate AQP4-and MOG-disease from MS
    Bensi, Catalina
    Gonzalez, Alejandra
    Chertcoff, Anibal
    Sanz, Emilia Osa
    Schteinschnaider, Angeles
    Correale, Jorge
    Farez, Mauricio
    NEUROLOGY, 2018, 90
  • [7] Brighter spotty lesion on spinal MRI: Is it helpful in differentiating AQP4 antibody positive neuromyelitis optica spectrum disorder from MOG antibody associated disease?
    Hyun, J-W
    Lee, H. L.
    Park, J.
    Kim, J.
    Min, J-H
    Kim, B. J.
    Kim, S. W.
    Shin, H. Y.
    Huh, S-Y
    Kim, W.
    Seo, J. W.
    Kim, K. H.
    Kim, S-H
    Kim, H. J.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 136 - 137
  • [8] Pain in AQP4-ab-positive and MOG-ab-positive neuromyelitis optica spectrum disorders
    Asseyer, S.
    Schmidt, F.
    Chien, C.
    Scheel, M.
    Ruprecht, K.
    Bellmann-Strobl, J.
    Brandt, A. U.
    Paul, F.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 819 - 820
  • [9] Central Vein Sign and Other Radiographic Features Distinguishing MOG Antibody Disease from Multiple Sclerosis and AQP4 Antibody-Positive Neuromyelitis Optica
    Ciotti, J. R.
    Eby, N. S.
    Wu, G. F.
    Chahin, S.
    Cross, A. H.
    Naismith, R. T.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (1_SUPPL) : 78 - 78
  • [10] Serum antinuclear antibodies associate with worse prognosis in AQP4-positive neuromyelitis optica spectrum disorder
    Fan, Rong
    Zhang, Yuefeng
    Xu, Yunqi
    Tong, Jiayi
    Chen, Zhigang
    Gu, Meifeng
    Fan, Wenkui
    Chen, Yong
    Peng, Fuhua
    Jiang, Ying
    BRAIN AND BEHAVIOR, 2021, 11 (01):